Serial 97855280
Live / Applied — Fourth extension granted (statement of use) (as of 02 Dec 2025)
What this means for you
Not registered yet, but its 24 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97855280
- Mark type
- Design / logo
- Filed
- 24 Mar 2023
- Published for opposition
- 10 Oct 2023
- Attorney of record
- Deborah L. Lively
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of vascular endothelial growth factor (VEGF) -mediated ocular diseases
Owner
- Adverum Biotechnologies, Inc., Redwood City, CA, US
- Adverum Biotechnologies, Inc., Redwood City, CA, US
Prosecution history
- 03 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2025 — SOU EXTENSION 4 GRANTED
- 02 Dec 2025 — SOU EXTENSION 4 FILED
- 02 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2025 — SOU EXTENSION 3 GRANTED
- 28 May 2025 — SOU EXTENSION 3 FILED
- 28 May 2025 — SOU TEAS EXTENSION RECEIVED
- 22 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2024 — SOU EXTENSION 2 GRANTED
- 20 Nov 2024 — SOU EXTENSION 2 FILED
- 20 Nov 2024 — SOU TEAS EXTENSION RECEIVED